Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
